• Comments

The Food and Drug Administration will evaluate "as quickly as possible" Pfizer's request to expand the emergency use authorization of the drug maker's COVID-19 vaccine to include people ages 12-15 in the United States, FDA Acting Commissioner Janet Woodcock said.